Table of Content




1. Executive Summary


2. Global Dengue Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Dengue Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Dengue Vaccine Market by Type
3.3.1: Live Attenuated Vaccine
3.3.2: Chimeric Live Attenuated Vaccine
3.3.3: Inactivated Vaccine
3.3.4: Subunit Vaccine
3.3.5: Nucleic Acid Based Vaccine

3.4: Global Dengue Vaccine Market by Treatment
3.4.1: Diuretic
3.4.2: Anti-Allergic
3.4.3: Blood Thinners
3.4.4: Others


3.5: Global Dengue Vaccine Market by Distribution Channel
3.5.1: Hospital Pharmacy
3.5.2: Online Pharmacy
3.5.3: Retail Pharmacy

3.6: Global Dengue Vaccine Market by End Use
3.6.1: Hospitals
3.6.2: Homecare
3.6.3: Specialty Clinics
3.6.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Dengue Vaccine Market by Region
4.2: North American Dengue Vaccine Market
4.2.1: North American Dengue Vaccine Market by Treatment: Diuretic, Anti-Allergic, Blood Thinners, and Others

4.2.2: North American Dengue Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

4.3: European Dengue Vaccine Market

4.3.1: European Dengue Vaccine Market by Treatment: Diuretic, Anti-Allergic, Blood Thinners, and Others

4.3.2: European Dengue Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

4.4: APAC Dengue Vaccine Market

4.4.1: APAC Dengue Vaccine Market by Treatment: Diuretic, Anti-Allergic, Blood Thinners, and Others

4.4.2: APAC Dengue Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

4.5: ROW Dengue Vaccine Market

4.5.1: ROW Dengue Vaccine Market by Treatment: Diuretic, Anti-Allergic, Blood Thinners, and Others

4.5.2: ROW Dengue Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Dengue Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Dengue Vaccine Market by Treatment
6.1.3: Growth Opportunities for the Global Dengue Vaccine Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Dengue Vaccine Market by End Use
6.1.5: Growth Opportunities for the Global Dengue Vaccine Market by Region

6.2: Emerging Trends in the Global Dengue Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Dengue Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dengue Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Mylan
7.2: BIO-MED
7.3: Teva Pharmaceutical
7.4: Sanofi
7.5: Novartis
7.6: GSK
7.7: F. Hoffmann-La Roche